Association between early detected heart failure stages and future cardiovascular and non-cardiovascular events in the elderly (Copenhagen Heart Failure Risk Study)

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Association between early detected heart failure stages and future cardiovascular and non-cardiovascular events in the elderly (Copenhagen Heart Failure Risk Study). / Parveen, Saaima; Zareini, Bochra; Arulmurugananthavadivel, Anojhaan; Kistorp, Caroline; Faber, Jens; Køber, Lars; Hassager, Christian; Sørensen, Tor Biering; Andersson, Charlotte; Zahir, Deewa; Iversen, Kasper; Wolsk, Emil; Gislason, Gunnar; Gaborit, Freja; Schou, Morten.

I: BMC Geriatrics, Bind 22, 230, 2022.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Parveen, S, Zareini, B, Arulmurugananthavadivel, A, Kistorp, C, Faber, J, Køber, L, Hassager, C, Sørensen, TB, Andersson, C, Zahir, D, Iversen, K, Wolsk, E, Gislason, G, Gaborit, F & Schou, M 2022, 'Association between early detected heart failure stages and future cardiovascular and non-cardiovascular events in the elderly (Copenhagen Heart Failure Risk Study)', BMC Geriatrics, bind 22, 230. https://doi.org/10.1186/s12877-022-02875-1

APA

Parveen, S., Zareini, B., Arulmurugananthavadivel, A., Kistorp, C., Faber, J., Køber, L., Hassager, C., Sørensen, T. B., Andersson, C., Zahir, D., Iversen, K., Wolsk, E., Gislason, G., Gaborit, F., & Schou, M. (2022). Association between early detected heart failure stages and future cardiovascular and non-cardiovascular events in the elderly (Copenhagen Heart Failure Risk Study). BMC Geriatrics, 22, [230]. https://doi.org/10.1186/s12877-022-02875-1

Vancouver

Parveen S, Zareini B, Arulmurugananthavadivel A, Kistorp C, Faber J, Køber L o.a. Association between early detected heart failure stages and future cardiovascular and non-cardiovascular events in the elderly (Copenhagen Heart Failure Risk Study). BMC Geriatrics. 2022;22. 230. https://doi.org/10.1186/s12877-022-02875-1

Author

Parveen, Saaima ; Zareini, Bochra ; Arulmurugananthavadivel, Anojhaan ; Kistorp, Caroline ; Faber, Jens ; Køber, Lars ; Hassager, Christian ; Sørensen, Tor Biering ; Andersson, Charlotte ; Zahir, Deewa ; Iversen, Kasper ; Wolsk, Emil ; Gislason, Gunnar ; Gaborit, Freja ; Schou, Morten. / Association between early detected heart failure stages and future cardiovascular and non-cardiovascular events in the elderly (Copenhagen Heart Failure Risk Study). I: BMC Geriatrics. 2022 ; Bind 22.

Bibtex

@article{2f3cc0f91604458a99cd5fe3a4fa120a,
title = "Association between early detected heart failure stages and future cardiovascular and non-cardiovascular events in the elderly (Copenhagen Heart Failure Risk Study)",
abstract = "Background: Early stages of heart failure (HF) are associated with an increased risk of hospitalization and increased mortality, however the course of progression and the impact of non-cardiovascular comorbidities on adverse events in elderly high-risk patients are unknown. Aim: To examine the risk of future cardiovascular (CV) and non-CV events in early stages of HF in a cohort of elderly patients (age ≥ 60 with ≥ 1 risk factor for HF and without known or clinically suspected HF). Methods: A total of 400 patients (American Heart Association HF stage A: N = 177; stage B: N = 150; stage C: N = 73) from the Copenhagen Heart Failure Risk Study were identified and followed for the main composite outcome of a HF hospitalization (HFH), ischemic heart disease (IHD), stroke, and all-cause death, recorded within the Danish nationwide registries. Non-CV hospitalization was a secondary outcome. Absolute risk was calculated by the Aalen-Johansen estimator. Results: The median follow-up time was 3.3 years, total number of events were 83, and the 3-year risk (95% confidence interval) of the main outcome was 12.8% (7.8–17.9), 22.8% (16.1–29.6) and 31.8% (21.0–42.6) for patients with stage A, B, and C, respectively. 1.1% (0.0–2.7), 3.4% (1.0–6.3) and 10.0% (2.8–16.3) experienced HFH as their first event, whereas 37.3% (30.2–44.4), 49.7% (41.6–57.8) and 54.8% (43.4–66.2) were admitted for non-CV causes as their first event. Conclusion: The risk of HFH, IHD, stroke and all-cause death increased with severity of HF stage, and 10% of patients with undiagnosed HF stage C were admitted for HF within 3 years. However, the risk of non-CV hospitalizations was greater compared to the risk of experiencing HFH.",
keywords = "All-cause mortality, Comorbidity, Heart failure, Heart failure stages, Population attributable risk",
author = "Saaima Parveen and Bochra Zareini and Anojhaan Arulmurugananthavadivel and Caroline Kistorp and Jens Faber and Lars K{\o}ber and Christian Hassager and S{\o}rensen, {Tor Biering} and Charlotte Andersson and Deewa Zahir and Kasper Iversen and Emil Wolsk and Gunnar Gislason and Freja Gaborit and Morten Schou",
note = "Publisher Copyright: {\textcopyright} 2022, The Author(s).",
year = "2022",
doi = "10.1186/s12877-022-02875-1",
language = "English",
volume = "22",
journal = "B M C Geriatrics",
issn = "1471-2318",
publisher = "BioMed Central Ltd.",

}

RIS

TY - JOUR

T1 - Association between early detected heart failure stages and future cardiovascular and non-cardiovascular events in the elderly (Copenhagen Heart Failure Risk Study)

AU - Parveen, Saaima

AU - Zareini, Bochra

AU - Arulmurugananthavadivel, Anojhaan

AU - Kistorp, Caroline

AU - Faber, Jens

AU - Køber, Lars

AU - Hassager, Christian

AU - Sørensen, Tor Biering

AU - Andersson, Charlotte

AU - Zahir, Deewa

AU - Iversen, Kasper

AU - Wolsk, Emil

AU - Gislason, Gunnar

AU - Gaborit, Freja

AU - Schou, Morten

N1 - Publisher Copyright: © 2022, The Author(s).

PY - 2022

Y1 - 2022

N2 - Background: Early stages of heart failure (HF) are associated with an increased risk of hospitalization and increased mortality, however the course of progression and the impact of non-cardiovascular comorbidities on adverse events in elderly high-risk patients are unknown. Aim: To examine the risk of future cardiovascular (CV) and non-CV events in early stages of HF in a cohort of elderly patients (age ≥ 60 with ≥ 1 risk factor for HF and without known or clinically suspected HF). Methods: A total of 400 patients (American Heart Association HF stage A: N = 177; stage B: N = 150; stage C: N = 73) from the Copenhagen Heart Failure Risk Study were identified and followed for the main composite outcome of a HF hospitalization (HFH), ischemic heart disease (IHD), stroke, and all-cause death, recorded within the Danish nationwide registries. Non-CV hospitalization was a secondary outcome. Absolute risk was calculated by the Aalen-Johansen estimator. Results: The median follow-up time was 3.3 years, total number of events were 83, and the 3-year risk (95% confidence interval) of the main outcome was 12.8% (7.8–17.9), 22.8% (16.1–29.6) and 31.8% (21.0–42.6) for patients with stage A, B, and C, respectively. 1.1% (0.0–2.7), 3.4% (1.0–6.3) and 10.0% (2.8–16.3) experienced HFH as their first event, whereas 37.3% (30.2–44.4), 49.7% (41.6–57.8) and 54.8% (43.4–66.2) were admitted for non-CV causes as their first event. Conclusion: The risk of HFH, IHD, stroke and all-cause death increased with severity of HF stage, and 10% of patients with undiagnosed HF stage C were admitted for HF within 3 years. However, the risk of non-CV hospitalizations was greater compared to the risk of experiencing HFH.

AB - Background: Early stages of heart failure (HF) are associated with an increased risk of hospitalization and increased mortality, however the course of progression and the impact of non-cardiovascular comorbidities on adverse events in elderly high-risk patients are unknown. Aim: To examine the risk of future cardiovascular (CV) and non-CV events in early stages of HF in a cohort of elderly patients (age ≥ 60 with ≥ 1 risk factor for HF and without known or clinically suspected HF). Methods: A total of 400 patients (American Heart Association HF stage A: N = 177; stage B: N = 150; stage C: N = 73) from the Copenhagen Heart Failure Risk Study were identified and followed for the main composite outcome of a HF hospitalization (HFH), ischemic heart disease (IHD), stroke, and all-cause death, recorded within the Danish nationwide registries. Non-CV hospitalization was a secondary outcome. Absolute risk was calculated by the Aalen-Johansen estimator. Results: The median follow-up time was 3.3 years, total number of events were 83, and the 3-year risk (95% confidence interval) of the main outcome was 12.8% (7.8–17.9), 22.8% (16.1–29.6) and 31.8% (21.0–42.6) for patients with stage A, B, and C, respectively. 1.1% (0.0–2.7), 3.4% (1.0–6.3) and 10.0% (2.8–16.3) experienced HFH as their first event, whereas 37.3% (30.2–44.4), 49.7% (41.6–57.8) and 54.8% (43.4–66.2) were admitted for non-CV causes as their first event. Conclusion: The risk of HFH, IHD, stroke and all-cause death increased with severity of HF stage, and 10% of patients with undiagnosed HF stage C were admitted for HF within 3 years. However, the risk of non-CV hospitalizations was greater compared to the risk of experiencing HFH.

KW - All-cause mortality

KW - Comorbidity

KW - Heart failure

KW - Heart failure stages

KW - Population attributable risk

U2 - 10.1186/s12877-022-02875-1

DO - 10.1186/s12877-022-02875-1

M3 - Journal article

C2 - 35313808

AN - SCOPUS:85126739577

VL - 22

JO - B M C Geriatrics

JF - B M C Geriatrics

SN - 1471-2318

M1 - 230

ER -

ID: 309125686